Causas de no consecución del objetivo terapéutico del colesterol de las lipoproteínas de baja densidad en pacientes de alto y muy alto riesgo vascular controlados en Unidades de Lípidos y Riesgo Vascular. Estudio EROMOT-Reference-Cited by-同舟云学术

Causas de no consecución del objetivo terapéutico del colesterol de las lipoproteínas de baja densidad en pacientes de alto y muy alto riesgo vascular controlados en Unidades de Lípidos y Riesgo Vascular. Estudio EROMOT

Published:2018-01 Issue:1 Volume:30 Page:1-9
ISSN:0214-9168
Container-title:Clínica e Investigación en Arteriosclerosis
language:es
Short-container-title:Clínica e Investigación en Arteriosclerosis

Author:

Morales Clotilde,Plana Núria,Arnau Anna,Matas Laia,Mauri Marta,Vila Àlex,Vila Lluís,Soler Cristina,Montesinos Jesús,Masana Lluís,Pedro-Botet Juan

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Reference35 articles.

1. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS);Reiner;Eur Heart J.,2011

2. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet.,2010

3. EUROASPIRE III: A survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries;Kotseva;Eur J Cardiovasc Prev Rehabil.,2009

4. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries;Kotseva;Eur J Prev Cardiol.,2016

5. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: The EURIKA study;Banegas;Eur Heart J.,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Observational study of patients from a Lipid Unit on lipid-modifying therapy for primary and secondary prevention: ULFI Study;Clínica e Investigación en Arteriosclerosis (English Edition);2023-11

2. Estudio observacional de pacientes de una Unidad de Lípidos en tratamiento hipolipemiante para prevención primaria y secundaria: Estudio ULFI;Clínica e Investigación en Arteriosclerosis;2023-07

3. Early approach to LDL-related risk after acute coronary syndrome: the OPTA project;Expert Review of Cardiovascular Therapy;2023-05-08

4. Superando las barreras en el abordaje del paciente crónico;Medicina de Familia. SEMERGEN;2023-03

5. LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals;Postgraduate Medicine;2022-10-06